IMT (Inflammatory Myofibroblastic Tumour) is a rather uncommon disease. The IMT was first discovered in the lungs. IMT can affect any part of the body, although the lungs, liver, and gastrointestinal tract are the most prevalent. It most commonly affects children and young adults, but it can affect anyone at any age. Clinically, IMTs are painless indurated masses/swelling that last for a short time, with signs and symptoms ranging from asymptomatic to nonspecific respiratory symptoms, fever, or discomfort, depending on the location of the tumour. IMTs have an underlying cause that is unknown. IMTs are tumours with an intermediate biological potential, meaning they can recur locally and have a small chance of spreading to other parts of the body. IMT is always debatable as to whether it is an inflammatory tumour or a tumour, and if it is benign or malignant, as well as the adjuvant treatment. Despite the pathologic findings and their apparent prognostic implications, the majority of those affected have had positive clinical outcomes, regardless of the originating site. A case of primary stomach IMT in an adult male is given here, along with a literature evaluation.
Author (S) Details
Department of Radiotherapy, All India Institute of Medical Sciences, Bhopal, India.
Department of General Surgery, All India Institute of Medical Sciences, Bhopal, India.
Department of Surgery, Mahatma Gandhi Institute of Medical Sciences, Sevagram, India.
View Book :- https://stm.bookpi.org/RDMMR-V2/article/view/4275